Trials
A look at Black and Hispanic Americans’ views on clinical trials
A participant in a phase three clinical trial receives a COVID-19 vaccine at the Research Centers of America in Hollywood, Florida, in August 2020....
Black, Latino patients underrepresented in ‘high-impact’ cirrhosis clinical trials in US
November 05, 2022
1 min read
Source/Disclosures
Published by:
Source:
Ufere N, et al. Underrepresentation of racial and ethni...
National Minority Quality Forum Launches Alliance for Representative Clinical Trials to Reduce Healthcare Disparities in Underserved Populations
For Immediate Release
WASHINGTON, D.C.—Today, National Minority Quality Forum (NMQF) announced the launch of the Alliance for Representative Clinic...
Minority clinical trials key to Walmart effort
Walmart Inc.’s latest dive into the health care arena involves reaching out to underrepresented populations for inclusion in clinical trials....
Disparities in awareness of and willingness to participate in cancer clinical trials between African American and White cancer survivors
Background:
Cancer clinical trials (CCTs) are essential for cancer care, yet the evidence is scarce when it comes to racial disparit...
Interventions to increase racial and ethnic minority accrual into cancer clinical trials: A systematic review
Background:
Racial and ethnic minorities (REMs) continue to be underrepresented in clinical trials despite the 1993 National Institu...
Trending Topics
Features
- Drive Toolkit
Download and distribute powerful vaccination QI resources for your community.
- Health Champions
Sign up now to support health equity and sustainable health outcomes in your community.
- Cancer Early Detection
MCED tests use a simple blood draw to screen for many kinds of cancer at once.
- PR
FYHN is a bridge connecting health information providers to BIPOC communities in a trusted environment.
- Medicare
Discover an honest look at our Medicare system.
- Alliance for Representative Clinical Trials
ARC was launched to create a network of community clinicians to diversify and bring clinical trials to communities of color and other communities that have been underrepresented.
- Reducing Patient Risk
The single most important purpose of our healthcare system is to reduce patient risk for an acute event.
